SINO PHARMACEUT Price to Book Ratio 2018-2021 | SBMFF

Historical price to book ratio values for SINO PHARMACEUT (SBMFF) over the last 10 years. The current price to book ratio for SINO PHARMACEUT as of October 15, 2021 is 3.57.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

SINO PHARMACEUT Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
0.00 nan
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.000B $3.426B
Sino Biopharmaceutical Limited researches, develops, produces and sells biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis. Sino Biopharmaceutical Limited is headquartered in Wanchai, Hong Kong.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00